Can I read Dose of Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy on EtoBox?

Dose of Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy by Yusuf A. Rajabally; Hanny Seow; Patrick Wilson is a Medicine article available to read on EtoBox.

What is Dose of Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy about?

**Abstract** The usual initiating dose of intravenous immunoglobulins (IVIg) in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) is 2 g/kg/course. Although not evidence based, subsequent reductions are advised to the lowest possible level for maintenance. In practice, the achievable levels of such reductions and their impact on treatment frequency have not been studied. Factors determining maximal dosage reduction are unknown. We retrospectively reviewed data concerning IVIg therapy for 15 patients with CIDP, from their medical records between 1997 and 2005. Lowest effective dose and treatment frequency were determined. The following correlations were ascertained: dose to frequency, dose to weight, dose to disease duration, amplitude of dose reduction to disease duration, and dose to pre‐therapeutic disease severity. Dose reductions were possible in all (mean: 63.3%, range: 42.4–88%). The lowest effective dose of IVIg per course and treatment frequency were both very variable (18–108 g and 2–17 weeks, respectively). Lowest dose per course did not correlate to weight, frequency of administration, disease duration, or pre‐therapeutic degree of disability. Amp

Who reads Dose of Intravenous Immunoglobulins in Chronic Inflammatory Demyelinating Polyneuropathy?

Author

Yusuf A. Rajabally; Hanny Seow; Patrick Wilson

Publisher

Wiley

Published

2006

Language

EN

Field

Medicine (Health Sciences)